Cargando…

Impact of intra-partum azithromycin on carriage of group A streptococcus in the Gambia: a posthoc analysis of a double-blind randomized placebo-controlled trial

BACKGROUND: Group A Streptococcus (GAS) is a major human pathogen and an important cause of maternal and neonatal sepsis. Asymptomatic bacterial colonization is considered a necessary step towards sepsis. Intra-partum azithromycin may reduce GAS carriage. METHODS: A posthoc analysis of a double-blin...

Descripción completa

Detalles Bibliográficos
Autores principales: Jagne, Isatou, Keeley, Alexander J., Bojang, Abdoulie, Camara, Bully, Jallow, Edrissa, Senghore, Elina, Oluwalana, Claire, Bah, Saikou Y., Turner, Claire E., Sesay, Abdul Karim, D’Alessandro, Umberto, Bottomley, Christian, de Silva, Thushan I., Roca, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800276/
https://www.ncbi.nlm.nih.gov/pubmed/35093029
http://dx.doi.org/10.1186/s12879-022-07080-4
_version_ 1784642225564549120
author Jagne, Isatou
Keeley, Alexander J.
Bojang, Abdoulie
Camara, Bully
Jallow, Edrissa
Senghore, Elina
Oluwalana, Claire
Bah, Saikou Y.
Turner, Claire E.
Sesay, Abdul Karim
D’Alessandro, Umberto
Bottomley, Christian
de Silva, Thushan I.
Roca, Anna
author_facet Jagne, Isatou
Keeley, Alexander J.
Bojang, Abdoulie
Camara, Bully
Jallow, Edrissa
Senghore, Elina
Oluwalana, Claire
Bah, Saikou Y.
Turner, Claire E.
Sesay, Abdul Karim
D’Alessandro, Umberto
Bottomley, Christian
de Silva, Thushan I.
Roca, Anna
author_sort Jagne, Isatou
collection PubMed
description BACKGROUND: Group A Streptococcus (GAS) is a major human pathogen and an important cause of maternal and neonatal sepsis. Asymptomatic bacterial colonization is considered a necessary step towards sepsis. Intra-partum azithromycin may reduce GAS carriage. METHODS: A posthoc analysis of a double-blind, placebo-controlled randomized-trial was performed to determine the impact of 2 g oral dose of intra-partum azithromycin on maternal and neonatal GAS carriage and antibiotic resistance. Following screening, 829 mothers were randomized who delivered 843 babies. GAS was determined by obtaining samples from the maternal and newborn nasopharynx, maternal vaginal tract and breastmilk. Whole Genome Sequencing (WGS) of GAS isolates was performed using the Illumina Miseq platform. RESULTS: GAS carriage was lower in the nasopharynx of both mothers and babies and breast milk among participants in the azithromycin arm. No differences in GAS carriage were found between groups in the vaginal tract. The occurrence of azithromycin-resistant GAS was similar in both arms, except for a higher prevalence in the vaginal tract among women in the azithromycin arm. WGS revealed all macrolide-resistant vaginal tract isolates from the azithromycin arm were Streptococcus dysgalactiae subspecies equisimilis expressing Lancefield group A carbohydrate (SDSE(A)) harbouring macrolide resistant genes msr(D) and mef(A). Ten of the 45 GAS isolates (22.2%) were SDSE(A). CONCLUSIONS: Oral intra-partum azithromycin reduced GAS carriage among Gambian mothers and neonates however carriage in the maternal vaginal tract was not affected by the intervention due to azithromycin resistant SDSE(A). SDSE(A) resistance must be closely monitored to fully assess the public health impact of intrapartum azithromycin on GAS. Trial registration ClinicalTrials.gov Identifier NCT01800942 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-022-07080-4.
format Online
Article
Text
id pubmed-8800276
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88002762022-02-02 Impact of intra-partum azithromycin on carriage of group A streptococcus in the Gambia: a posthoc analysis of a double-blind randomized placebo-controlled trial Jagne, Isatou Keeley, Alexander J. Bojang, Abdoulie Camara, Bully Jallow, Edrissa Senghore, Elina Oluwalana, Claire Bah, Saikou Y. Turner, Claire E. Sesay, Abdul Karim D’Alessandro, Umberto Bottomley, Christian de Silva, Thushan I. Roca, Anna BMC Infect Dis Research BACKGROUND: Group A Streptococcus (GAS) is a major human pathogen and an important cause of maternal and neonatal sepsis. Asymptomatic bacterial colonization is considered a necessary step towards sepsis. Intra-partum azithromycin may reduce GAS carriage. METHODS: A posthoc analysis of a double-blind, placebo-controlled randomized-trial was performed to determine the impact of 2 g oral dose of intra-partum azithromycin on maternal and neonatal GAS carriage and antibiotic resistance. Following screening, 829 mothers were randomized who delivered 843 babies. GAS was determined by obtaining samples from the maternal and newborn nasopharynx, maternal vaginal tract and breastmilk. Whole Genome Sequencing (WGS) of GAS isolates was performed using the Illumina Miseq platform. RESULTS: GAS carriage was lower in the nasopharynx of both mothers and babies and breast milk among participants in the azithromycin arm. No differences in GAS carriage were found between groups in the vaginal tract. The occurrence of azithromycin-resistant GAS was similar in both arms, except for a higher prevalence in the vaginal tract among women in the azithromycin arm. WGS revealed all macrolide-resistant vaginal tract isolates from the azithromycin arm were Streptococcus dysgalactiae subspecies equisimilis expressing Lancefield group A carbohydrate (SDSE(A)) harbouring macrolide resistant genes msr(D) and mef(A). Ten of the 45 GAS isolates (22.2%) were SDSE(A). CONCLUSIONS: Oral intra-partum azithromycin reduced GAS carriage among Gambian mothers and neonates however carriage in the maternal vaginal tract was not affected by the intervention due to azithromycin resistant SDSE(A). SDSE(A) resistance must be closely monitored to fully assess the public health impact of intrapartum azithromycin on GAS. Trial registration ClinicalTrials.gov Identifier NCT01800942 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-022-07080-4. BioMed Central 2022-01-29 /pmc/articles/PMC8800276/ /pubmed/35093029 http://dx.doi.org/10.1186/s12879-022-07080-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Jagne, Isatou
Keeley, Alexander J.
Bojang, Abdoulie
Camara, Bully
Jallow, Edrissa
Senghore, Elina
Oluwalana, Claire
Bah, Saikou Y.
Turner, Claire E.
Sesay, Abdul Karim
D’Alessandro, Umberto
Bottomley, Christian
de Silva, Thushan I.
Roca, Anna
Impact of intra-partum azithromycin on carriage of group A streptococcus in the Gambia: a posthoc analysis of a double-blind randomized placebo-controlled trial
title Impact of intra-partum azithromycin on carriage of group A streptococcus in the Gambia: a posthoc analysis of a double-blind randomized placebo-controlled trial
title_full Impact of intra-partum azithromycin on carriage of group A streptococcus in the Gambia: a posthoc analysis of a double-blind randomized placebo-controlled trial
title_fullStr Impact of intra-partum azithromycin on carriage of group A streptococcus in the Gambia: a posthoc analysis of a double-blind randomized placebo-controlled trial
title_full_unstemmed Impact of intra-partum azithromycin on carriage of group A streptococcus in the Gambia: a posthoc analysis of a double-blind randomized placebo-controlled trial
title_short Impact of intra-partum azithromycin on carriage of group A streptococcus in the Gambia: a posthoc analysis of a double-blind randomized placebo-controlled trial
title_sort impact of intra-partum azithromycin on carriage of group a streptococcus in the gambia: a posthoc analysis of a double-blind randomized placebo-controlled trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800276/
https://www.ncbi.nlm.nih.gov/pubmed/35093029
http://dx.doi.org/10.1186/s12879-022-07080-4
work_keys_str_mv AT jagneisatou impactofintrapartumazithromycinoncarriageofgroupastreptococcusinthegambiaaposthocanalysisofadoubleblindrandomizedplacebocontrolledtrial
AT keeleyalexanderj impactofintrapartumazithromycinoncarriageofgroupastreptococcusinthegambiaaposthocanalysisofadoubleblindrandomizedplacebocontrolledtrial
AT bojangabdoulie impactofintrapartumazithromycinoncarriageofgroupastreptococcusinthegambiaaposthocanalysisofadoubleblindrandomizedplacebocontrolledtrial
AT camarabully impactofintrapartumazithromycinoncarriageofgroupastreptococcusinthegambiaaposthocanalysisofadoubleblindrandomizedplacebocontrolledtrial
AT jallowedrissa impactofintrapartumazithromycinoncarriageofgroupastreptococcusinthegambiaaposthocanalysisofadoubleblindrandomizedplacebocontrolledtrial
AT senghoreelina impactofintrapartumazithromycinoncarriageofgroupastreptococcusinthegambiaaposthocanalysisofadoubleblindrandomizedplacebocontrolledtrial
AT oluwalanaclaire impactofintrapartumazithromycinoncarriageofgroupastreptococcusinthegambiaaposthocanalysisofadoubleblindrandomizedplacebocontrolledtrial
AT bahsaikouy impactofintrapartumazithromycinoncarriageofgroupastreptococcusinthegambiaaposthocanalysisofadoubleblindrandomizedplacebocontrolledtrial
AT turnerclairee impactofintrapartumazithromycinoncarriageofgroupastreptococcusinthegambiaaposthocanalysisofadoubleblindrandomizedplacebocontrolledtrial
AT sesayabdulkarim impactofintrapartumazithromycinoncarriageofgroupastreptococcusinthegambiaaposthocanalysisofadoubleblindrandomizedplacebocontrolledtrial
AT dalessandroumberto impactofintrapartumazithromycinoncarriageofgroupastreptococcusinthegambiaaposthocanalysisofadoubleblindrandomizedplacebocontrolledtrial
AT bottomleychristian impactofintrapartumazithromycinoncarriageofgroupastreptococcusinthegambiaaposthocanalysisofadoubleblindrandomizedplacebocontrolledtrial
AT desilvathushani impactofintrapartumazithromycinoncarriageofgroupastreptococcusinthegambiaaposthocanalysisofadoubleblindrandomizedplacebocontrolledtrial
AT rocaanna impactofintrapartumazithromycinoncarriageofgroupastreptococcusinthegambiaaposthocanalysisofadoubleblindrandomizedplacebocontrolledtrial